Campylobacter fetus infection presenting with bacteremia and cellulitis in a 72-year-old man with an implanted pacemaker: a case report
© Ledina et al.; licensee BioMed Central Ltd. 2012
Received: 26 April 2012
Accepted: 16 October 2012
Published: 30 November 2012
Campylobacter is an important causative agent of intestinal infections in humans. Bacteremia is detected in less than 1% of patients, mainly in immunocompromised patients and in extreme age groups. Cellulitis is a relatively common manifestation of Campylobacter infection, but concomitant bacteremia is a rare event. Infections of the pacemaker area are caused primarily by staphylococci, followed by fungi, streptococci and Gram-negative rods. To the best of our knowledge, this is the first case report of pacemaker pocket infection and bacteremia caused by Campylobacter fetus.
A 72-year-old Croatian Caucasian man with myelodysplasia, impaired fasting glucose levels and a recently implanted permanent pacemaker was admitted to hospital after six days of fever, development of red swelling of the pacemaker pocket area and worsening of his general condition. No antibiotic therapy was introduced in the outpatient setting. He denied any recent gastrointestinal disturbances. With the exception of an elevated leukocyte count, erythrocyte sedimentation rate, and C-reactive protein and blood glucose levels, other laboratory findings were normal. Treatment with vancomycin plus netilmicin was introduced, and a surgical incision with drainage of the pacemaker pocket was performed. The entire pacemaker system was removed and a new one re-implanted after 14 days of antibiotic therapy. Transesophageal echocardiography showed no pathological findings. Three subsequent blood cultures obtained on admission as well as swab culture of the incised pacemaker area revealed Campylobacter fetus; stool and pacemaker lead cultures were negative. According to the microbiological results, antibiotic therapy was changed to ciprofloxacin plus netilmicin. A clinical examination and the results of a laboratory analysis performed after two weeks of therapy were within normal limits.
Myelodysplasia, impaired fasting glucose levels and older age could be contributing factors for the development of bacteremic Campylobacter fetus cellulitis. Emergent surgical and antibiotic treatment are mandatory and provide the optimal outcome for such types of pacemaker pocket infection.
To date, 15 species of Campylobacter are known. Campylobacter is an important cause of intestinal infection in humans. These microorganisms sporadically cause bacteremia or extraintestinal infections. Less than 1% of patients with diarrhea caused by Campylobacter species develop bacteremia. Invasive disease usually occurs in immunocompromised patients and in persons at the extremes of age. Contaminated poultry, meat and unpasteurized milk are usual sources of Campylobacter infection, but direct spreading from infected animals is also possible. Intestinal infections are most commonly caused by C. jejuni. Extraintestinal manifestations are rare and include meningitis, endocarditis, septic arthritis and osteomyelitis[4, 5]. C. fetus has been recognized as the major causative agent of extraintestinal infections. Cellulitis is a relatively common manifestation of Campylobacter infection but concomitant bacteremia is rare. Infections of the pacemaker area are primarily caused by staphylococci, followed by fungi, streptococci and Gram-negative rods. Retention of an infected pacemaker system is associated with high mortality.
Cases of C. fetus endocarditis, as well as infection of an internal cardioverter defibrillator, have previously been described. To the best of our knowledge, only one article regarding pacemaker site Campylobacter infection has been published thus far. We report the case of a patient with myelodysplasia and diabetes mellitus who, 14 days after implantation of a permanent pacemaker, developed bacteremic cellulitis of a pacemaker site infection caused by C. fetus.
A 72-year-old Croatian Caucasian man was admitted to our hospital with fever of up to 40°C, inflammation of the pacemaker pocket area and progressive general weakness. Five years prior to this hospital admission, our patient was diagnosed with myelodysplastic syndrome and he had an impaired fasting glucose level that was treated with diet only. The current symptoms commenced two weeks after the implantation of a permanent pacemaker. He developed low grade fever up to 37.5°C accompanied by general weakness. On the seventh day of his disease, fever with chills rose up to 40°C and he was referred to our Department of Infectious Diseases. He denied any gastrointestinal disturbances including diarrhea or abdominal pain during or before this illness. He also denied close contact with animals and eating of undercooked meat or unpasteurized milk. He received no antibiotic therapy in the outpatient setting.
On physical examination there was painful red swelling of the pacemaker area, 15cm in diameter, with dehiscence of the surgical suture and serous leakage evident on his right chest region. His heart rhythm was regular with a systolic heart murmur, but our patient was hemodynamically stable. His arterial pressure was 140/70mmHg, and heart rate 84 beats/min. Bronchial rales were heard on the right side of his chest. Hepatomegaly and splenomegaly were not registered. Laboratory tests revealed an erythrocyte sedimentation rate of 96mm/h. His leukocyte count was 17.9×109/L (86% polymorphonuclear cells), erythrocytes 2.86×1012/L, hemoglobin concentration 9.9g/dL and platelet count 242×109/L. His C-reactive protein level was 156μmol/L, and blood glucose level 9.06mmol/L. Other blood biochemical parameters (creatinine, blood urea nitrogen, total protein, albumin, globulin, immunoglobulin, amylase, serum aspartate aminotransferase, alanine aminotransferase, bilirubin, creatine phosphokinase and alkaline phosphates) were within the reference ranges. A chest X-ray showed no pulmonary infiltrations. Transthoracic, as well as transesophageal echocardiography showed no signs of endocarditis. Blood, urine and wound swabs were obtained and vancomycin plus netilmicin introduced as empiric therapy. Swab culture of the infected region and three consecutive blood cultures revealed C. fetus. Urine, stool and pacemaker lead cultures obtained later, were negative.
Cultures of swabs and blood samples, plated on charcoal-based blood-free selective medium, incubated under microaerobic (5% O2, 10% CO2 and 85% N2) conditions at 25°C and 35°C resulted in the growth of gray, flat, irregular, spreading colonies after 48 hours.
The Gram stain showed a characteristic appearance of Gram-negative, curved to S-shaped rods. The identification of the strain was performed on the basis of conventional biochemical tests. An antibiotic susceptibility test, performed by using the E-test (PDM Epsilometer; AB Biodisc, Solna, Sweden), gave these minimum inhibitory concentrations for the following antimicrobial agents: ampicillin 0.12mg/L, tetracycline 0.25mg/L, erythromycin 0.19mg/L and ciprofloxacin 0.064mg/L. Minimum inhibitory concentration breakpoints were interpreted according to the guideline established by the British Society for Antimicrobial Chemotherapy.
Our patient was transferred to our Department of Cardiology where a local surgical incision and removal of the permanent pacemaker by simple traction were performed. The pacemaker pocket was drained and the wound closed by secondary sutures. Surgical drainage was followed by an immediate drop in the fever. According to the antibiotic susceptibility of C. fetus, therapy was switched to ciprofloxacin plus netilmicin. Our patient’s condition improved quickly following the treatment. Repeated blood cultures obtained during and at the end of the second week of therapy were negative. A new pacemaker system was re-implanted 14 days after his admission to our hospital, at the contralateral side of his thorax. Three days later, our patient was discharged from hospital. One month later, the area of cellulitis had healed completely, and there were no signs of inflammation of the contralaterally implanted pacemaker.
This is the first case report of pacemaker pocket infection and bacteremia caused by C. fetus. Bacteremia caused by C. fetus is a rare event, particularly in immunocompetent hosts. C. fetus has an affinity for vascular endothelium, and different cardiovascular complications such as endocarditis, thrombophlebitis, pericarditis and mycotic aneurysms have been reported[1, 5]. Some degree of immunodeficiency appears to be mandatory for the development of extraintestinal Campylobacter infections. C. fetus bacteremia is a serious infection that is often accompanied by relapses and complications despite the prompt administration of the appropriate antibiotics. Human immunodeficiency virus infection, alcoholism, cirrhosis, old age, pregnancy, diabetes mellitus, malignancies, beta-thalassemia, systemic lupus erythematosus, inherited immunodeficiencies, transplantation and splenectomy have all been recognized as important risk factors for the development of serious C. fetus infection[5, 6]. In our patient, diabetes mellitus and myelodysplasia could have been contributing factors to the severe pacemaker pocket infection and bacteremia. Another recognized cause of serious extraintestinal infections is C. lari. After reviewing the literature, we found one case of pacemaker infection caused by C. lari. In eight cases of C. lari bacteremia, only two had gastrointestinal symptoms[9, 10]. Isolation of C. lari and C. fetus in several cases of prosthetic device infections encouraged an opinion of their propensity to cause such types of infections[11, 12].
Although in our case, an intestinal source of infection was not proven, it cannot be ruled out as a stool culture was obtained during empiric therapy that included an aminoglycoside. The negative culture of the pacemaker lead could also be a consequence of previously introduced aminoglycoside therapy. Therefore, the mode of pacemaker pocket infection for our patient remains unclear: direct inoculation during insertion of the pacemaker or hematogenous spread originating from an asymptomatic intestinal infection.
Most authors recommend a combination of removal of cardiac devices, either surgically or by a transvenous route, with antimicrobial therapy. Percutaneous removal of infected pacemakers combined with appropriate antibiotic therapy is safe and effective, as shown in our case. Both simple traction and countertraction techniques can be used with low risk of complications. The mortality of patients with retained infected pacemaker systems is high. Therefore, removal of both the pacemaker generator and leads is essential in case of an infection. Fortunately, as in our case, pulse generator pocket infection is quite rarely complicated by infective endocarditis.
C. fetus is a rare but possible cause of serious pacemaker pocket site infection. In particular it should be considered as a causative agent in patients with underling illnesses that are contributing factors for a wider spectrum of causative agents. The best treatment results are obtained with a combination of surgical and antimicrobial therapy.
Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
- Miki R, Maekura R, Hiraga T, Hirotani A, Hashimoto H, Kitada S, Miki M: Infective tricuspid valve endocarditis with pulmonary emboli caused by Campylobacter fetus after tooth extraction. Intern Med. 2005, 44: 1055-1059. 10.2169/internalmedicine.44.1055.View ArticlePubMed
- Monselise A, Blickstein D, Ostfeld I, Segal R, Weinberger M: A case of cellulitis complicating Campylobacter jejuni subspecies jejuni bacteremia and review of the literature. Eur J Clin Microbiol Infect Dis. 2004, 23: 718-721.View ArticlePubMed
- Allos BM: Campylobacter jejuni infections: update on emerging issues and trends. Clin Infect Dis. 2001, 32: 1201-1206. 10.1086/319760.View ArticlePubMed
- Fernández-Cruz A, Muñoz P, Mohedano R, Valerio M, Marin M, Alcalá L, Rodriguez-Créixems M, Cercenado E, Bouza E: Campylobacter bacteremia: clinical characteristics, incidence, and outcome over 23 years. Medicine. 2010, 89 (5): 319-330. 10.1097/MD.0b013e3181f2638d.View ArticlePubMed
- Pigrau C, Bartolome R, Almirante B, Planes AM, Gavalda J, Pahissa A: Bacteremia due to Campylobacter species: clinical findings and antimicrobial susceptibility patterns. Clin Infect Dis. 1997, 25: 1414-1420. 10.1086/516127.View ArticlePubMed
- Zonios DI, Panayiotakopoulos GD, Kabletsas EO, Tzima EL, Stefanou I, Archimandritis AJ: Campylobacter fetus bacteremia in a healthy individual: clinical and therapeutical implications. J Infect. 2005, 51: 329-332. 10.1016/j.jinf.2004.08.023.View ArticlePubMed
- Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson RW, Steckelberg JM: Risk factor analysis of permanent pacemaker infection. Clin Infect Dis. 2007, 45: 166-173. 10.1086/518889.View ArticlePubMed
- Ahram W, Johnson D, Richards M, Strathmore N: Campylobacter fetus infection of an internal cardioverter defibrillator. PACE. 2008, 31: 258-259. 10.1111/j.1540-8159.2007.00981.x.View Article
- Morris CN, Scully B, Garvey GJ: Campylobacter lari associated with permanent pacemaker infection and bacteremia. Clin Infect Dis. 1998, 27: 220-221. 10.1086/517683.View ArticlePubMed
- Pacanowski J, Lalande V, Lacombe K, Boudraa C, Lesprit P, Legrand P, Trystram D, Kassis N, Arlet G, Mainardi JL, Doucet-Populaire F, Girard PM, Meynard JL, CAMPYL Study Group: Campylobacter bacteremia: clinical features and factors associated with fatal outcome. Clin Infect Dis. 2008, 47: 790-796. 10.1086/591530.View ArticlePubMed
- Dzau VJ, Schur PH, Winstein L: Vibrio fetus endocarditis in a patient with systemic lupus erythematosus. Am J Med Sci. 1976, 272: 331-334. 10.1097/00000441-197611000-00010.View ArticlePubMed
- Haruyama A, Toyoda S, Kikuchi M, Arikawa T, Inami S, Otani N, Amano H, Matsuda R, Inoue T: Campylobacter fetus as cause of prosthetic valve endocarditis. Tex Heart Inst J. 2011, 38: 584-587.PubMed CentralPubMed
- Post JJ, Alexopulos C, Fewtrell C, Giles R, Jones PD: Outcome after complete percutaneous removal of infected pacemaker system and implantable cardiac defibrillators. Intern Med J. 2006, 36: 790-792. 10.1111/j.1445-5994.2006.01221.x.View ArticlePubMed
- Rettig G, Doenecke P, SenSVolkmer I, Bette L: Complications with retained transvenous pacemaker electrodes. Am Heart J. 1979, 98: 587-594. 10.1016/0002-8703(79)90284-9.View ArticlePubMed
- Baddour LM, Cha YM, Wilson WR: Infections of cardiovascular implantable electronic devices. N Engl J Med. 2012, 367: 842-849. 10.1056/NEJMcp1107675.View ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.